Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Proper reconstitution ensures stable potency and accurate dosing
680-47-544), the CIFAR Azrieli Global Scholars Program and the EMBO Young Investigator Award
Yildiz, I
The majority of clinical trials investigating disease-modifying therapies have sought to halt or reverse the deposition of specific proteins in the brain and, while the first disease-modifying drug targeting protein deposition has been approved for AD (Kharel and Ojha, 2023)
US$ 21.62
US$ 25.10
US$ 23.14
US$ 21.27
US$ 25.98
US$ 28.66
US$ 25.86
